Back to Journals » Therapeutics and Clinical Risk Management » Volume 22 » default

Therapeutics and Clinical Risk Management

COPE logo
ISSN: 1178-203X

Archive: Volume 22, 2026

Staged Management of Bone Defects in Chronic Osteomyelitis and Nonunions Using Antibiotic-Loaded Calcium Sulphate-Hydroxyapatite: A Multicenter Retrospective Analysis of 101 Cases

Armbruster J, Mattern N, Lamadé-Dootz F, Steinhausen ES, Reiter G, Dudda M, Grützner PA, Freischmidt H

Therapeutics and Clinical Risk Management 2026, 22:599996

Published Date: 8 May 2026

rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors

Naja K, Elashi AA, Hedaya L, Anwardeen NR, Al-Shafai M, Rizzo M, Elrayess MA

Therapeutics and Clinical Risk Management 2026, 22:578286

Published Date: 28 April 2026

Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study

Tan H, Zhou J, Shi S, Jiang L, Zuo L, Su A, Wang H, Sun Y, Xuan W, Chi Y

Therapeutics and Clinical Risk Management 2026, 22:564176

Published Date: 15 April 2026

Real-World Evidence on Statin Use for Traumatic Brain Injury Associated Degenerative Neurological Disorders

Lin YH, Tsai IJ, Chang YA, Huang CH, Chang CC

Therapeutics and Clinical Risk Management 2026, 22:591742

Published Date: 26 March 2026

Preoperative Portal Vein Thrombosis Grading Predicts Post-Transplant Thrombosis and Survival

Liu Y, Tian JS, Wang YN, Wang ZR, Cao J, Shi ZY

Therapeutics and Clinical Risk Management 2026, 22:565328

Published Date: 25 March 2026

Clinical and Procedural Predictive Model for Pneumothorax Risk After CT-Guided Lung Biopsy

Qin Y, Zhao Z, Zhang L, Shao X, Wang Q

Therapeutics and Clinical Risk Management 2026, 22:579698

Published Date: 5 February 2026

Ten-Year Outcomes of Modular Reverse Shoulder Arthroplasty Assessed by 3D Motion Analysis

Hetto P, Liewald F, Maier MW, Tsitlakidis S, Spranz D

Therapeutics and Clinical Risk Management 2026, 22:546875

Published Date: 20 January 2026

Clinical Outcomes of Percutaneous Mitral Valve Repair with Mitraclip®: A Longitudinal Observational Study (The Mitra-Angio-CDO Study)

Melo-Burbano LÁ, Bonilla-Bonilla DM, Daza-Arana JE, Lozada-Ramos H, Dager AE, Fonseca JA

Therapeutics and Clinical Risk Management 2026, 22:549225

Published Date: 17 January 2026

Prospective Evaluation of Postoperative SIRS and Serum Inflammatory Indices in Percutaneous Nephrolithotomy Patients

Arslantas YB, Sonmez G, Baydilli N, Bas U, Tosun H, Demirci D, Akinsal EC

Therapeutics and Clinical Risk Management 2026, 22:568497

Published Date: 15 January 2026

Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom

Heinze A, Afridi SK, Totev TI, Krasenbaum LJ, Terasawa E, Akcicek H, Hipp J, Dhiraj D, Sun R, Yim E, Yilma B, Driessen MT

Therapeutics and Clinical Risk Management 2026, 22:529550

Published Date: 14 January 2026

Comparison of a Kidney Intensive Care Unit Healthcare-Led Model versus a Traditional Haemodialysis Nurse-Led Model for Continuous Renal Replacement Therapy: A Retrospective Observational Study

Zhang T, Jiang G, Yan H, Wang J, Lan X, Bai J, Deng Y, Zhang N, Gao Q, Shen Y, Wang X, Wei R

Therapeutics and Clinical Risk Management 2026, 22:545995

Published Date: 10 January 2026